Thomas Dennis, Abramson Michael J, Bonevski Billie, George Johnson
Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville Campus, 381 Royal Parade, Parkville, Victoria, Australia, 3052.
Epidemiology & Preventive Medicine, School of Public Health & Preventive Medicine, Monash University, Melbourne, Victoria, Australia, 3004.
Cochrane Database Syst Rev. 2017 Feb 10;2(2):CD010742. doi: 10.1002/14651858.CD010742.pub2.
System change interventions for smoking cessation are policies and practices designed by organizations to integrate the identification of smokers and the subsequent offering of evidence-based nicotine dependence treatments into usual care. Such strategies have the potential to improve the provision of smoking cessation support in healthcare settings, and cessation outcomes among those who use them.
To assess the effectiveness of system change interventions within healthcare settings, for increasing smoking cessation or the provision of smoking cessation care, or both.
We searched databases including the Cochrane Tobacco Addiction Group Specialized Register, CENTRAL, MEDLINE, Embase, CINAHL, and PsycINFO in February 2016. We also searched clinical trial registries: WHO clinical trial registry, US National Institute of Health (NIH) clinical trial registry. We checked 'grey' literature, and handsearched bibliographies of relevant papers and publications.
Randomized controlled trials (RCTs), cluster-RCTs, quasi-RCTs and interrupted time series studies that evaluated a system change intervention, which included identification of all smokers and subsequent offering of evidence-based nicotine dependence treatment.
Using a standardized form, we extracted data from eligible studies on study settings, participants, interventions and outcomes of interest (both cessation and system-level outcomes). For cessation outcomes, we used the strictest available criteria to define abstinence. System-level outcomes included assessment and documentation of smoking status, provision of advice to quit or cessation counselling, referral and enrolment in quitline services, and prescribing of cessation medications. We assessed risks of bias according to the Cochrane Handbook and categorized each study as being at high, low or unclear risk of bias. We used a narrative synthesis to describe the effectiveness of the interventions on various outcomes, because of significant heterogeneity among studies.
We included seven cluster-randomized controlled studies in this review. We rated the quality of evidence as very low or low, depending on the outcome, according to the GRADE standard. Evidence of efficacy was equivocal for abstinence from smoking at the longest follow-up (four studies), and for the secondary outcome 'prescribing of smoking cessation medications' (two studies). Four studies evaluated changes in provision of smoking cessation counselling and three favoured the intervention. There were significant improvements in documentation of smoking status (one study), quitline referral (two studies) and quitline enrolment (two studies). Other secondary endpoints, such as asking about tobacco use (three studies) and advising to quit (three studies), also indicated some positive effects.
AUTHORS' CONCLUSIONS: The available evidence suggests that system change interventions for smoking cessation may not be effective in achieving increased cessation rates, but have been shown to improve process outcomes, such as documentation of smoking status, provision of cessation counselling and referral to smoking cessation services. However, as the available research is limited we are not able to draw strong conclusions. There is a need for additional high-quality research to explore the impact of system change interventions on both cessation and system-level outcomes.
戒烟的系统变革干预措施是组织设计的政策和实践,旨在将吸烟者的识别以及随后提供基于证据的尼古丁依赖治疗纳入常规护理。此类策略有可能改善医疗环境中戒烟支持的提供情况,以及使用这些策略者的戒烟效果。
评估医疗环境中系统变革干预措施在提高戒烟率或提供戒烟护理或两者兼而有之方面的有效性。
我们于2016年2月检索了多个数据库,包括Cochrane烟草成瘾小组专业注册库、Cochrane系统评价数据库、医学期刊数据库、荷兰医学文摘数据库、护理学与健康领域数据库和心理学文摘数据库。我们还检索了临床试验注册库:世界卫生组织临床试验注册库、美国国立卫生研究院临床试验注册库。我们查阅了“灰色”文献,并手工检索了相关论文和出版物的参考文献目录。
评估系统变革干预措施的随机对照试验(RCT)、整群随机对照试验、半随机对照试验和中断时间序列研究,该干预措施包括识别所有吸烟者并随后提供基于证据的尼古丁依赖治疗。
我们使用标准化表格,从符合条件的研究中提取有关研究背景、参与者、干预措施和感兴趣的结局(戒烟和系统层面结局)的数据。对于戒烟结局,我们使用最严格的可用标准来定义戒断。系统层面结局包括吸烟状况的评估和记录、提供戒烟建议或戒烟咨询、转介至戒烟热线服务并登记以及开具戒烟药物。我们根据Cochrane手册评估偏倚风险,并将每项研究归类为高、低或偏倚风险不明确。由于研究之间存在显著异质性,我们使用叙述性综合分析来描述干预措施对各种结局的有效性。
我们在本综述中纳入了七项整群随机对照研究。根据GRADE标准,根据结局不同,我们将证据质量评为极低或低。在最长随访期时戒烟(四项研究)以及次要结局“开具戒烟药物”(两项研究)的疗效证据不明确。四项研究评估了戒烟咨询提供情况的变化,三项研究支持干预措施。吸烟状况记录(一项研究)、戒烟热线转介(两项研究)和戒烟热线登记(两项研究)有显著改善。其他次要终点,如询问烟草使用情况(三项研究)和建议戒烟(三项研究),也显示出一些积极效果。
现有证据表明,戒烟的系统变革干预措施可能无法有效提高戒烟率,但已证明可改善过程结局,如吸烟状况记录、提供戒烟咨询和转介至戒烟服务。然而,由于现有研究有限,我们无法得出强有力的结论。需要更多高质量研究来探索系统变革干预措施对戒烟和系统层面结局的影响。